| Year |
Citation |
Score |
| 2018 |
Zhou J, Lazar D, Li H, Xia X, Satheesan S, Charlins P, O'Mealy D, Akkina R, Saayman S, Weinberg MS, Rossi JJ, Morris KV. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1. Theranostics. 8: 1575-1590. PMID 29556342 DOI: 10.7150/Thno.23085 |
0.322 |
|
| 2017 |
Pang KM, Castanotto D, Li H, Scherer L, Rossi JJ. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy. Nucleic Acids Research. PMID 29077949 DOI: 10.1093/Nar/Gkx980 |
0.307 |
|
| 2014 |
Chung J, Scherer LJ, Gu A, Gardner AM, Torres-Coronado M, Epps EW, Digiusto DL, Rossi JJ. Optimized lentiviral vectors for HIV gene therapy: multiplexed expression of small RNAs and inclusion of MGMT(P140K) drug resistance gene. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 952-63. PMID 24576853 DOI: 10.1038/Mt.2014.32 |
0.318 |
|
| 2012 |
Chung J, Zhang J, Li H, Ouellet DL, DiGiusto DL, Rossi JJ. Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy. Human Gene Therapy. 23: 1200-8. PMID 22834872 DOI: 10.1089/Hum.2012.011 |
0.314 |
|
| 2011 |
Zhou J, Rossi JJ. Aptamer-targeted RNAi for HIV-1 therapy. Methods of Molecular Biology. 721: 355-371. PMID 21431697 DOI: 10.1007/978-1-61779-037-9_22 |
0.308 |
|
| 2011 |
Zhou J, Rossi JJ. Progress in RNAi-based Antiviral Therapeutics Methods of Molecular Biology. 721: 67-75. PMID 21431679 DOI: 10.1007/978-1-61779-037-9_4 |
0.307 |
|
| 2010 |
DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A, Mi S, Yam P, Stinson S, Kalos M, Alvarnas J, Lacey SF, Yee JK, Li M, Couture L, ... ... Rossi JJ, et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Science Translational Medicine. 2: 36ra43. PMID 20555022 DOI: 10.1126/Scitranslmed.3000931 |
0.31 |
|
| 2006 |
Morris KV, Rossi JJ. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection. Human Gene Therapy. 17: 479-86. PMID 16716105 DOI: 10.1089/Hum.2006.17.479 |
0.322 |
|
| 2006 |
Robbins MA, Li M, Leung I, Li H, Boyer DV, Song Y, Behlke MA, Rossi JJ. Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nature Biotechnology. 24: 566-71. PMID 16648841 DOI: 10.1038/Nbt1206 |
0.306 |
|
| 2005 |
Amarzguioui M, Rossi JJ, Kim D. Approaches for chemically synthesized siRNA and vector‐mediated RNAi Febs Letters. 579: 5974-5981. PMID 16199038 DOI: 10.1016/J.Febslet.2005.08.070 |
0.302 |
|
| 2005 |
Gonzalez S, Castanotto D, Li H, Olivares S, Jensen MC, Forman SJ, Rossi JJ, Cooper LJ. Amplification of RNAi--targeting HLA mRNAs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 811-8. PMID 15851019 DOI: 10.1016/J.Ymthe.2004.12.023 |
0.307 |
|
| 2003 |
Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS. Anticancer Research. 23: 1997-2005. PMID 12894572 |
0.32 |
|
| 2002 |
Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nature Biotechnology. 20: 500-505. PMID 11981565 DOI: 10.1038/Nbt0502-500 |
0.332 |
|
| Show low-probability matches. |